Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study

Trial Profile

Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Apixaban (Primary)
  • Indications Venous thrombosis
  • Focus Therapeutic Use
  • Acronyms CAP
  • Most Recent Events

    • 07 Jun 2016 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
    • 07 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 31 Oct 2015 New Source identified and integrated ( European ClinicalTrialsDatabase:EudraCT2014-005439-15 )
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top